Back

Type 2 diabetes increases the need for pacemaker and implantable cardioverter defibrillator treatment- A Swedish registry report

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Novel aspects of anti bradycardia pacing Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Elina Rautio

Karolinska Institute, Stockholm (Sweden)

10 More presentations in this session

Presentation thumbnail
Ventricular pacing percentage and atrial fibrillation risk in dual chamber cardiac implantable devices.
Doctor M. Landolina (Crema, IT)
Abstract Slides
Presentation thumbnail
Right ventricular septal pacing with narrow QRS less than 125ms is beneficial for preventing pacing induced cardiomyopathy
Professor D. Kim (Seoul, KR)
Abstract
Presentation thumbnail
Comparision of transjugular versus transfemoral approach for temporary pacemaker implantation
Associate Professor K. Chun (Chuncheon, KR)
Abstract
Presentation thumbnail
Paced corrected QT interval is associated with LV diastolic dysfunction in patients with permanent pacemakers and preserved left ventricular ejection fraction
Doctor O. Kaypakli (Adana, TR)
Abstract
Presentation thumbnail
Comparison of electrocardiogram characteristics between left bundle branch pacing and right ventricular septal pacing in patients receiving pacemaker therapy
Professor K. Chen (Beijing, CN)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 7 - Novel aspects of anti bradycardia pacing

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources